These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30343496)

  • 1. Dose translation between laboratory animals and human in preclinical and clinical phases of drug development.
    Nair A; Morsy MA; Jacob S
    Drug Dev Res; 2018 Dec; 79(8):373-382. PubMed ID: 30343496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interspecies scaling and comparisons in drug development and toxicokinetics.
    Ings RM
    Xenobiotica; 1990 Nov; 20(11):1201-31. PubMed ID: 2275215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple practice guide for dose conversion between animals and human.
    Nair AB; Jacob S
    J Basic Clin Pharm; 2016 Mar; 7(2):27-31. PubMed ID: 27057123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of allometric scaling principles to predict pharmacokinetic parameters across species.
    Huang Q; Riviere JE
    Expert Opin Drug Metab Toxicol; 2014 Sep; 10(9):1241-53. PubMed ID: 24984569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research tools for extrapolating the disposition and pharmacokinetics of nanomaterials from preclinical animals to humans.
    Valic MS; Zheng G
    Theranostics; 2019; 9(11):3365-3387. PubMed ID: 31244958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translating dosages from animal models to human clinical trials--revisiting body surface area scaling.
    Blanchard OL; Smoliga JM
    FASEB J; 2015 May; 29(5):1629-34. PubMed ID: 25657112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory animal species.
    Riviere JE; Martin-Jimenez T; Sundlof SF; Craigmill AL
    J Vet Pharmacol Ther; 1997 Dec; 20(6):453-63. PubMed ID: 9430769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches for predicting human pharmacokinetics using interspecies pharmacokinetic scaling.
    Kang HE; Lee MG
    Arch Pharm Res; 2011 Nov; 34(11):1779-88. PubMed ID: 22139680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling.
    Kirman CR; Sweeney LM; Meek ME; Gargas ML
    Regul Toxicol Pharmacol; 2003 Dec; 38(3):345-67. PubMed ID: 14623485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal studies on medicinal herbs: predictability, dose conversion and potential value.
    Wojcikowski K; Gobe G
    Phytother Res; 2014 Jan; 28(1):22-7. PubMed ID: 23553964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interspecies extrapolation.
    Kenyon EM
    Methods Mol Biol; 2012; 929():501-20. PubMed ID: 23007441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Hypoglycemic Studies of Polyherbal Phytoceuticals, Their Pharmacokinetic Studies and Dose Extrapolation by Allometric Scaling.
    De B; Bhandari K; Katakam P; Mitra A
    Curr Drug Discov Technol; 2017; 14(4):277-292. PubMed ID: 28359233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of the pharmacokinetic parameters of reduced-dolasetron in man using in vitro-in vivo and interspecies allometric scaling.
    Sanwald-Ducray P; Dow J
    Xenobiotica; 1997 Feb; 27(2):189-201. PubMed ID: 9058532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled efficacious dose translation from rodent to human: A retrospective analysis of clinical standards for respiratory diseases.
    Phillips JE
    Pharmacol Ther; 2017 Oct; 178():141-147. PubMed ID: 28442326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of absorbed dose extrapolation methods for mouse-to-human translation of radiolabelled macromolecules.
    Cicone F; Viertl D; Denoël T; Stabin MG; Prior JO; Gnesin S
    EJNMMI Res; 2022 Apr; 12(1):21. PubMed ID: 35403982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model-Based Interspecies Scaling for Predicting Human Pharmacokinetics of CB 4332, a Complement Factor I Protein.
    Ayoun Alsoud R; Le Moan N; Holten-Andersen L; Knudsen T; Lennernäs H; Simonsson USH
    J Pharm Sci; 2024 Jun; ():. PubMed ID: 38945365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial allometric factor extrapolation: compartmental and physiological pharmacokinetic approaches.
    Hill TA; Wands RC
    Health Phys; 1989; 57 Suppl 1():395-401. PubMed ID: 2514157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The allometric approach for interspecies scaling of pharmacokinetics and toxicity of anti-cancer drugs.
    Paxton JW
    Clin Exp Pharmacol Physiol; 1995 Nov; 22(11):851-4. PubMed ID: 8593743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrapolation of Oligonucleotide Dose Levels Used in Nonclinical Toxicity Studies to Selection of Safe Starting Dose Levels in Human Clinical Trials.
    Kornbrust D
    Nucleic Acid Ther; 2019 Jun; 29(3):123-125. PubMed ID: 30817231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetic principles behind scaling from preclinical results to phase I protocols.
    Mahmood I; Balian JD
    Clin Pharmacokinet; 1999 Jan; 36(1):1-11. PubMed ID: 9989339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.